More Than 25% Of Patients Coinfected With Virologically-Suppressed HIV And Chronic HBV Experience HBV Replication Event After Two Years Of Tenofovir-Based ART, Study Finds

December 08, 2022

Infectious Disease Advisor (12/7, Nye) reports, “More than 25% of patients coinfected with virologically-suppressed HIV and chronic hepatitis B virus (HBV) experienced an HBV replication event after 2 years of tenofovir-based antiretroviral therapy (ART),...